Morbidity and drug utilization pattern among admitted pregnant anemic women and to find out rationality of drug by using Indian guidelines


  • Harsh M. Joshi Department of Pharmacology, NHL Municipal Medical College, Ahmadabad, Gujarat, India
  • Jayun M. Joshi Department of Obstetrics and Gynecology, LG Hospital, Ahmedabad, Gujarat, India
  • Kamlesh P. Patel Department of Pharmacology, NHL Municipal Medical College, Ahmadabad, Gujarat, India
  • Kartik N. Shah Department of Pharmacology, NHL Municipal Medical College, Ahmadabad, Gujarat, India
  • Varsha J. Patel Department of Pharmacology, NHL Municipal Medical College, Ahmadabad, Gujarat, India


Anemia, Drug utilization, World Health Organization core drug prescribing indicators


Background: Pregnancy represents a special physiological state during which the use of drug is of growing concern due to risk of teratogenicity. Anemia is common threat to mother. Therefore, our aim was to study the drug utilization, teratogenic risk among patients of anemia in pregnancy and check rationality of prescriptions.

Methods: An observational, prospective study was carried out in 150 indoor patients in the tertiary care hospital. Protocol was approved by the Institutional Review Board. The data were collected in a pre-designed proforma. Data were analyzed using SPSS version 20.0 Software.

Results: Among 150 patients, 23, 111, and 16 were of <20, 20-30 and more than 30 years of age respectively. Among anemic patients Pregnancy induced hypertension (18.7%), antepartum hemorrhage (12.7%) were common. About 71% women have complaint of weakness, followed by headache. Iron (93.3%) and calcium (86.0%) were the most common drugs prescribed. Iron sucrose and packed cell volume given in severe anemia. Drug risk category, Category A (90.21%) was most frequently prescribed, which is followed by Category B (8.0%) and Category C (1.8%). Percentage of drugs prescribed by generic name and from essential drug list was 70.3 and 89.2. Overall prescribing habit was rational according to Indian guideline.

Conclusion: Iron, calcium, and folic acid were most commonly prescribed drugs in anemic patients. No teratogenic risk was found out during drug use. Drug and dose of the drug was rational and appropriate. There is lesser number of drugs prescribed by generic name and hospital supply.


DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q. 1985;38(3):302-16.

Micronutrient deficiency: battling iron deficiency anemia: the challenge. WHOL; 2004. Available at: Accessed 24 Apr 2014.

Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347-60.

Toteja GS, Singh P. Micronutrient Profile of Indian Population. New Delhi: Indian Council of Medical Research; 2004:23-6.

National Nutrition Monitoring Bureau (NNMB). NNMB Micronutrient Survey. Technical Report 22. Hyderabad: National Institute of Nutrition; 2003:13-5.

Kapur D, Agarwal KN, Sharma S, Kela K, Kaur I. Iron status of children aged 9-36 months in an urban slum Integrated child development services project in Delhi. J Indian Pediatr. 2002;139:136-44.

Prema K, Neela Kumari S, Ramalakshmi BA. Anemia and adverse obstetric outcome. Nutr Rep Int. 1981;23:637-43.

Frankos VH. FDA perspectives on the use of teratology data for human risk assessment. Fundam Appl Toxicol. 1985;5(4):615-25.

How to Investigate Drug Use in Health Facilities, Selected Drug Use Indicators, WHO/DAP/93.1. Geneva: World Health Organization; 1993:10. Available at Assessed 20 Feb 2014.

World Health Organization. WHO Collaborative Centre for Drug Utilization Research and Clinical Pharmacological Services, 2003. Available at Accessed 20 Feb 2014.

Bondevik GT, Lie RT, Ulstein M, Kvåle G. Maternal hematological status and risk of low birth weight and preterm delivery in Nepal. Acta Obstet Gynecol Scand. 2001;80(5):402-8.

Abel R, Rajaratnam J, Gnanasekaran VJ, Jayaraman P. Prevalence of anaemia and iron deficiency in three trimesters in Rural Vellore district, South India. Trop Doct. 2001;31(2):86-9.

Milman N, Bergholt T, Byg KE, Eriksen L, Graudal N. Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand. 1999;78(9):749-57.

Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-5.

Hernández-Díaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol. 2002;156(9):806-12.

Ahmed F. Anaemia in Bangladesh: a review of prevalence and aetiology. Public Health Nutr. 2000;3(4):385-93.

Kiwanuka GN, Isharaza WK, Mahmoud S. Iron status of pregnant women at first antenatal booking in Mbarara University Teaching Hospital. Trop Doct. 1999;29(4):228-30.

Awan MM, Akbar MA, Khan MI. A study of anemia in pregnant women of railway colony, Multan. Pak J Med. 2004;43(1):112-5.

Badgery-Parker T, Ford JB, Jenkins MG, Morris JM, Roberts CL. Patterns and outcomes of preterm hospital admissions during pregnancy in NSW, 2001-2008. Med J Aust. 2012;196(4):261-5.

Gebreegziabher TL, Berhe DF, Gutema GB, Kabtyimer BN. Drug utilization pattern and potential teratogenesity risk among pregnant women; Ethiopia. Int J Pharm Sci Res. 2012;3(5):1371-8.

Hernández B, Ortiz-Panozo E, Pérez-Cuevas R. Facility-based care for delivery and management of complications related to pregnancy and childbirth in Mexico. Salud Publica Mex. 2012;54(5):496-505.

Cogswell ME, Kettel-Khan L, Ramakrishnan U. Iron supplement use among women in the United States: science, policy and practice. J Nutr. 2003;133(6):1974S-77.

Hess SY, Zimmermann MB, Brogli S, Hurrell RF. A national survey of iron and folate status in pregnant women in Switzerland. Int J Vitam Nutr Res. 2001;71(5):268-73.

Das B, Sarkar C, Datta A, Bohra S. A study of drug use during pregnancy in a teaching hospital in Western Nepal. Pharmacoepidemiol Drug Saf. 2003;12(3):221-5.

Rizk MA, Abdel-Aziz F, Ashmawy AA, Mahmoud AA, Abuzeid TM. Knowledge and practices of pregnant women in relation to the intake of drugs during pregnancy. J Egypt Public Health Assoc. 1993;68(5-6):567-91.

Moradi F, Mohammadi S, Kadiva AA, Masoumi SJ. Knowledge and practice of pregnant women in Fars province about intake of iron supplements. Acta Med Iran. 2007;45(4):299-304.

Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, De Jong-Van Den Berg LT. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006;113(5):559-68.

Malm H, Martikainen J, Kalukka T, Neuvonen PJ. Prescription of hazardous during pregnancy. Drug Saf. 2004;27:899-908.

Tisonová J, Magulová L, Göböová M, Wawruch M, Lassánová M, Bozeková L, et al. Consultation activity of two Slovak centres for pharmacotherapy during pregnancy and lactation. Cas Lek Cesk. 2006;145(2):154-7.




How to Cite

Joshi, H. M., Joshi, J. M., Patel, K. P., Shah, K. N., & Patel, V. J. (2017). Morbidity and drug utilization pattern among admitted pregnant anemic women and to find out rationality of drug by using Indian guidelines. International Journal of Basic & Clinical Pharmacology, 3(6), 947–953. Retrieved from



Original Research Articles